# IDVYNSO
> **NDA216964** · New Drug Application · Sponsor: MSD · Approved 2026-04-20
## Drug
- **FDA Application Number:** NDA216964
- **Application type:** New Drug Application
- **Brand name:** IDVYNSO
- **Generic name:** DORAVIRINE, ISLATRAVIR
- **Active ingredients:** DORAVIRINE; ISLATRAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSD
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2026-04-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216964)
---
*AI Analytics · CC0 1.0*